Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services.
Our purpose is to enable people with allergies to live normal lives.
Allergy Immunotherapy is the only targeted treatment for patients with respiratory allergies that adequately rebalances the immune system, inducing gradual tolerance to allergens.
With 1,400 employees worldwide, a presence in more than 20 countries, a distribution network in 75 countries and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France).
With complementary strengths, and shared heritage and reputations, Stallergenes Greer continues to lead the field in Allergy Immunotherapy.
Would you like to be involved in the development of a leading global expert in a highly dynamic and multicultural international environment?
Join our Stallergenes Greer teams!